Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

Unfortunately Gerald "double talked" his loyal and ardent shareholders. You can not talk-up shareholder value and share price appreciation while diluting over 1-Bil. shares in 3 years time - it just doesn't work that way. That said, I get it. AMBS is a start-up and cash strapped - with an amazing BOA and BOD, and an incredible Dx and Therapeutic pipeline, in various stages of maturation. However, were are much closer to award winning revenue now, then the past 2 years as you've indicated. If I had to guess when we can expect blockbuster revenue news, I would say between April and June. Until then, were into the 2nd Bil. AS to survive. It's just that simple.